Extended Data Fig. 6: PT regression and necrosis in the path-evaluable patient population.
From: Association between pathologic response and survival after neoadjuvant therapy in lung cancer
Paired pretreatment and on-treatment %regression-PT and %necrosis-PT in tissue specimens from individual patients by (a) histology (n = 24, squamous; n = 23, nonsquamous) and (b) treatment arm (n = 17, nivolumab plus chemotherapy; n = 30, chemotherapy). PT denotes primary tumor.
